Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Brun

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
AIDS (London, England)|May 30, 2024
Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, FrancePierre Leroy, Sylvain Diamantis, Pierre-Olivier Sellier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 20, 2024
Brief Report: Pancreatic Cancer in People With HIV: A Case-Control StudySylvain Chawki, Gwenn Hamet, Alexandre Brun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2023
Brief Report: Incidence and Management of Complex Kidney Situations Among On-Demand and Daily HIV Pre-Exposure Prophylaxis UsersGeoffroy Liegeon, Alexandre Brun, Gwenn Hamet, et al.
AIDS Research and Human Retroviruses|October 1, 2019
Mortality of People Living with HIV in Paris Area from 2011 to 2015Pierre Sellier, Gwenn Hamet, Alexandre Brun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in FranceYousra Kherabi, Nathalie de Castro, Pierre-Olivier Sellier, et al.
AIDS (London, England)|September 14, 2018
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in FranceMarion Noret, Stéphanie Balavoine, Claire Pintado, et al.
AIDS (London, England)|July 10, 2023
Updated mortality and causes of death in 2020-2021 in people with HIV: a multicenter study in FrancePierre Sellier, Guylaine Alexandre-Castor, Alexandre Brun, et al.
AIDS Research and Therapy|January 3, 2023
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort studyNathalie De Castro, Alexandre Brun, Pierre Sellier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
AIDS (London, England)|May 30, 2024
Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, FrancePierre Leroy, Sylvain Diamantis, Pierre-Olivier Sellier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 20, 2024
Brief Report: Pancreatic Cancer in People With HIV: A Case-Control StudySylvain Chawki, Gwenn Hamet, Alexandre Brun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2023
Brief Report: Incidence and Management of Complex Kidney Situations Among On-Demand and Daily HIV Pre-Exposure Prophylaxis UsersGeoffroy Liegeon, Alexandre Brun, Gwenn Hamet, et al.
AIDS Research and Human Retroviruses|October 1, 2019
Mortality of People Living with HIV in Paris Area from 2011 to 2015Pierre Sellier, Gwenn Hamet, Alexandre Brun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in FranceYousra Kherabi, Nathalie de Castro, Pierre-Olivier Sellier, et al.
AIDS (London, England)|September 14, 2018
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in FranceMarion Noret, Stéphanie Balavoine, Claire Pintado, et al.
AIDS (London, England)|July 10, 2023
Updated mortality and causes of death in 2020-2021 in people with HIV: a multicenter study in FrancePierre Sellier, Guylaine Alexandre-Castor, Alexandre Brun, et al.
AIDS Research and Therapy|January 3, 2023
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort studyNathalie De Castro, Alexandre Brun, Pierre Sellier, et al.
Pageof 1